SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-16-005880
Filing Date
2016-05-11
Accepted
2016-05-11 17:16:35
Documents
46
Period of Report
2016-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q tcon-20160331x10q.htm 10-Q 1122425
2 EX-31.1 tcon-20160331ex31109cc5c.htm EX-31.1 12049
3 EX-31.2 tcon-20160331ex3121f0b36.htm EX-31.2 12086
4 EX-32.1 tcon-20160331ex321585b87.htm EX-32.1 7345
5 EX-32.2 tcon-20160331ex3221bd061.htm EX-32.2 7442
6 GRAPHIC tcon20160331x10q001.jpg GRAPHIC 155356
7 GRAPHIC tcon20160331x10q002.jpg GRAPHIC 78605
  Complete submission text file 0001558370-16-005880.txt   3979287

Data Files

Seq Description Document Type Size
8 EX-101.INS tcon-20160331.xml EX-101.INS 616072
9 EX-101.SCH tcon-20160331.xsd EX-101.SCH 27996
10 EX-101.CAL tcon-20160331_cal.xml EX-101.CAL 37881
11 EX-101.DEF tcon-20160331_def.xml EX-101.DEF 98581
12 EX-101.LAB tcon-20160331_lab.xml EX-101.LAB 271341
13 EX-101.PRE tcon-20160331_pre.xml EX-101.PRE 192537
Mailing Address 8910 UNIVERSITY CENTER DRIVE SUITE 700 San Diego CA 92122
Business Address 8910 UNIVERSITY CENTER DRIVE SUITE 700 San Diego CA 92122 858-550-0780
Tracon Pharmaceuticals, Inc. (Filer) CIK: 0001394319 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36818 | Film No.: 161640808
SIC: 2836 Biological Products, (No Diagnostic Substances)